RETRACTED: Clinical application of subharmonic aided pressure estimation (SHAPE) in the assessment of portal hypertension in patients with decompensated cirrhosis: A pilot study
Clinical Hemorheology and Microcirculation · 2025
DOI: 10.1177/13860291241304056 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Clinical Hemorheology and Microcirculation, 2025. Verfasst von Yunlin Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Hypertension, Portal, Liver Cirrhosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
PurposeThe aim of the study was to explore the possibility of subharmonic aided pressure estimation (SHAPE) measurement for noninvasive evaluation of portal hypertension in patients with decompensated liver cirrhosis.Materials and MethodsPatients diagnosed with decompensated liver cirrhosis were prospectively enrolled. SHAPE measurement was performed by using an ultrasound system. A continuous infusion of sonazoid at a rate of 0.18 ml/kg/h and saline at 120 ml/h was performed. The hepatic venous pressure gradient (HVPG) value are the gold standard for evaluating portal hypertension. The Pearson coefficient and areas under the receiver operating characteristic curves (AUCs) were analyzed.ResultsFrom February 2023 to August 2023, 15 patients (mean age, 61.1 ± 8.3 years; eight men and seven women) were included. The correlation coefficient of the SHAPE gradient and HVPG was 0.33. The mean SHAPE gradient of patients with clinically significant portal hypertension (CSPH) (HVPG ≥ 10 mmHg) was significantly higher than that of patients with lower risk (0.5 ± 4.4 dB vs. -7.4 ± 5.1 dB, P = 0.01). Patients with increased risk for variceal hemorrhage (HVPG ≥ 12 mmHg) had a significantly higher mean SHAPE gradient than patients with lower risk (HVPG < 12 mmHg) (1.3 ± 4.4 dB vs. -5.9 ± 4.8 dB; P = 0.01). The optimal cut-off values of the SHAPE gradient for diagnosing patients with CSPH and at increased risk for variceal hemorrhage were -1.3 dB and -0.6 dB (both AUC = 0.89), respectively.ConclusionSHAPE measurement is a potential noninvasive, effective imaging method to evaluate portal hypertension among patients diagnosed with decompensated liver cirrhosis in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China.
- Yunlin Huang and Xiuyun Lu share the co-first authorship.
Zitieren
APA
Huang, Y., Lu, X., Wang, F., Cao, J., Wang, Y., Cheng, J., Dong, Y., & Wang, W. (2025). RETRACTED: Clinical application of subharmonic aided pressure estimation (SHAPE) in the assessment of portal hypertension in patients with decompensated cirrhosis: A pilot study. Clinical Hemorheology and Microcirculation. https://doi.org/10.1177/13860291241304056
Vancouver
Huang Y, Lu X, Wang F, Cao J, Wang Y, Cheng J, et al. RETRACTED: Clinical application of subharmonic aided pressure estimation (SHAPE) in the assessment of portal hypertension in patients with decompensated cirrhosis: A pilot study. Clinical Hemorheology and Microcirculation. 2025. doi:10.1177/13860291241304056
BibTeX
@article{Huang2025,
author = {Huang, Yunlin and Lu, Xiuyun and Wang, Feihang and Cao, Jiaying and Wang, Ying and Cheng, Juan and Dong, Yi and Wang, Wenping},
title = {RETRACTED: Clinical application of subharmonic aided pressure estimation (SHAPE) in the assessment of portal hypertension in patients with decompensated cirrhosis: A pilot study},
journal = {Clinical Hemorheology and Microcirculation},
year = {2025},
doi = {10.1177/13860291241304056}
}
EUVIMED